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We thank Dr Pedersen and colleagues for their interest in our work (1) and we 
welcome the external validation of the Royal Free Hospital Cirrhosis Glomerular 
Filtration Rate (GFR) (2). As a general comment, the equation performs very well in 
this independent cohort and only slightly underestimates true GFR, unlike widely 
used formulas such as the MDRD. We would also like to discuss a few additional 
points. 
Firstly, since the publication of our article we have discovered an error in the 
originally reported formula and we have submitted an erratum, which is in press. 
The correct formula should read: 
GFR= 45·9x(creatinine
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)x1·236(if male)x0·92(if moderate/severe ascites). 
We presume that the GFR underestimation will be less pronounced should the 
authors use the corrected formula. 
Secondly, Cr-51 EDTA measurement in patients with ascites is more reliable when 
plasma samples are taken up to 24 hours post injection rather than just 6 hours (3, 
4). This could have resulted in small inaccuracy of the “gold standard” measurement 
in the Danish cohort. 
Thirdly, it would be of interest if the authors could show how did the Royal Free 
Hospital cirrhosis GFR perform compared to other widely used GFR formulas in this 
independent dataset. This would encourage a more widespread use of this equation.  
Ultimately, as we mentioned in our article, it would be valuable to explore if the 
incorporation of this cirrhosis-specific GFR equation instead of creatinine in 
prognostic scores such as MELD improves their performance; we are in the process 
of testing this using data from the NHS British Transplant database. 
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